{"id":43500,"date":"2024-12-14T11:02:52","date_gmt":"2024-12-14T04:02:52","guid":{"rendered":"https:\/\/www.intouchmedicare.com\/?p=43500"},"modified":"2026-04-22T14:00:50","modified_gmt":"2026-04-22T07:00:50","slug":"pep-brand-drug-kocitaf-en","status":"publish","type":"post","link":"https:\/\/www.intouchmedicare.com\/en\/pep-brand-drug-kocitaf-en","title":{"rendered":"What is KOCITAF? HIV PEP After Exposure"},"content":{"rendered":"

KOCITAF is an antiretroviral medication used as post-exposure prophylaxis (PEP) to help prevent HIV infection after a potential exposure.<\/span> <\/strong>This medication combines three antiretroviral drugs in a single tablet.<\/span><\/p>\n

People who may have recently been at risk, such as through unprotected sex, condom breakage or slippage, or contact with blood or bodily fluids, should seek medical attention immediately. A doctor will assess whether KOCITAF is appropriate.<\/span> PEP is most effective when started within 72 hours after exposure,<\/span> and the sooner it is taken, the better the protection. It is also important to understand how to take the medication, the correct dosage, cost, and possible side effects.<\/span><\/p>\n

<\/div>
<\/div>
\n
\n\n\t
\n\t\t\t\t
\n\t\t\t\n\t\t\t\n

A medical check, correct use of PEP, and follow-up HIV tests as advised by a doctor are important for the best protection. \"\"<\/span><\/p>\n\t\t<\/div>\n\t\t\t\t\t<\/div>\n\n\t\n<\/div>\n<\/div><\/div><\/div>\n\t

\n\t\t\n